» Articles » PMID: 23549761

Initial Experience from a Large Referral Center with Robotic-assisted Ivor Lewis Esophagogastrectomy for Oncologic Purposes

Overview
Journal Surg Endosc
Publisher Springer
Date 2013 Apr 4
PMID 23549761
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We report our initial experience of patients undergoing robotic-assisted Ivor Lewis esophagogastrectomy (RAIL) for oncologic purposes at a large-referral center.

Methods: A retrospective review of all consecutive patients undergoing RAIL from 2010-2011 was performed. Basic demographics were recorded. Oncologic variables recorded included: tumor type, location, postoperative tumor margins, and nodal harvest. Immediate 30-day postoperative complications also were analyzed.

Results: Fifty patients underwent RAIL with median age of 66 (range 42-82) years. The mean body mass index was 28.6 ± 0.7 kg/m(2); 54% and the majority had an American Society of Anesthesiologists classification of 3. The mean and median number of lymph nodes retrieved during surgery was 20 ± 1.4 and 18.5 respectively. R0 resections were achieved in all patients. Postoperative complications occurred in 14 (28%) patients, including atrial fibrillation in 5 (10%), pneumonia in 5 (10%), anastomotic leak in 1 (2%), conduit staple line leak in 1 (2%), and chyle leak in 2 (4%). The median ICU stay and length of hospitalization (LOH) were 2 and 9 days respectively. Total mean operating time calculated from time of skin incision to wound closure was 445 ± 85 minutes; however, operative times decreased over time. Similarly, there was a trend toward lower complications after the first 29 cases but this did not reach statistical significance. There were no in-hospital mortalities.

Conclusions: We demonstrated that RAIL for esophageal cancer can be performed safely and may be associated with fewer complications after a learning curve, shorter ICU stay, and LOH.

Citing Articles

Totally minimally invasive laparoscopic robot-assisted Ivor Lewis esophagectomy: improved technique and outcomes over 200 cases.

Drake J, Sinnamon A, Saeed S, Mehta R, Palm R, Baldonado J J Gastrointest Oncol. 2024; 15(2):544-554.

PMID: 38756649 PMC: 11094488. DOI: 10.21037/jgo-23-923.


Is Robotic Surgery the Future for Resectable Esophageal Cancer?: A Systematic Literature Review of Oncological and Clinical Outcomes.

Patel N, Patel P, Yeung K, Monk D, Mohammadi B, Mughal M Ann Surg Oncol. 2024; 31(7):4281-4297.

PMID: 38480565 PMC: 11164768. DOI: 10.1245/s10434-024-15148-5.


Robotic-Assisted Esophagectomy: Current Situation and Future Perspectives.

Watanabe M, Kuriyama K, Terayama M, Okamura A, Kanamori J, Imamura Y Ann Thorac Cardiovasc Surg. 2023; 29(4):168-176.

PMID: 37225478 PMC: 10466119. DOI: 10.5761/atcs.ra.23-00064.


Robot-assisted Ivor Lewis Esophagectomy (RAILE): A review of surgical techniques and clinical outcomes.

Shen T, Zhang Y, Cao Y, Li C, Li H Front Surg. 2022; 9:998282.

PMID: 36406371 PMC: 9672456. DOI: 10.3389/fsurg.2022.998282.


Minimally invasive esophagectomy.

Bograd A, Molena D Curr Probl Surg. 2021; 58(10):100984.

PMID: 34629156 PMC: 9089813. DOI: 10.1016/j.cpsurg.2021.100984.


References
1.
Melis M, Weber J, McLoughlin J, Siegel E, Hoffe S, Shridhar R . An elevated body mass index does not reduce survival after esophagectomy for cancer. Ann Surg Oncol. 2010; 18(3):824-31. PMC: 4623586. DOI: 10.1245/s10434-010-1336-1. View

2.
Clark J, Sodergren M, Purkayastha S, Mayer E, James D, Athanasiou T . The role of robotic assisted laparoscopy for oesophagogastric oncological resection; an appraisal of the literature. Dis Esophagus. 2010; 24(4):240-50. DOI: 10.1111/j.1442-2050.2010.01129.x. View

3.
Weksler B, Sharma P, Moudgill N, Chojnacki K, Rosato E . Robot-assisted minimally invasive esophagectomy is equivalent to thoracoscopic minimally invasive esophagectomy. Dis Esophagus. 2011; 25(5):403-9. DOI: 10.1111/j.1442-2050.2011.01246.x. View

4.
Lee J, Yun J, Nam K, Choi U, Chung W, Soh E . Perioperative clinical outcomes after robotic thyroidectomy for thyroid carcinoma: a multicenter study. Surg Endosc. 2010; 25(3):906-12. DOI: 10.1007/s00464-010-1296-3. View

5.
Santillan A, Farma J, Meredith K, Shah N, Kelley S . Minimally invasive surgery for esophageal cancer. J Natl Compr Canc Netw. 2008; 6(9):879-84. DOI: 10.6004/jnccn.2008.0066. View